Mark de Rosch

Mark De Rosch, PhD, FRAPS, is a seasoned executive in the pharmaceutical and biotechnology sectors with extensive expertise in regulatory affairs, program management, and drug development across a variety of therapeutic areas including neurodegeneration, oncology, and ophthalmology. Currently serving as Senior Vice President of Regulatory and Government Affairs at CervoMed since November 2024, Mark has held notable positions such as Chief Development Officer at Samsara Therapeutics and Chief Operating Officer at Aura Biosciences. Mark's diverse experience encompasses small molecule and biologic modalities, with a strong focus on global regulatory strategy and team-building. Mark holds a PhD in Inorganic Chemistry from UC San Diego and a B.S. in Chemistry/Biochemistry from the University of Wisconsin-Parkside.